Final-Program-ATS-2023-AP.vp

MONDAY • MAY 22

175

P42 Large Pneumatocele as a Rare Complication in COVID-19 (Delta Variant) Pneumonia/ A. Gillissen, Reutlingen, Germany P43 A Case of Immune Thrombocytopenic Purpura Secondary to COVID-19 Infection/ A. Acharya, Kathmandu, Nepal P44 Modulation of Sphingolipid Metabolism and SARS-CoV-2 Infection in Lung/ S.L. Single, Birmingham, AL P45 Remdesivir and Survival Outcomes in Critically Ill Patients With COVID-19: A Multicentre Observational Cohort Study/ C. Cilloniz Campos, Barcelona, Spain P46 Evaluation of a Point of Care Rapid Antibody Test for the Diagnosis of Corona Virus Disease-19 (COVID-19) Infection in Indian Population/ A. Mohan, New Delhi, India P47 Assessing the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for Managing COVID-19 Patients: A Systematic Review and Meta-Analysis/ F. Zhou, Hamilton, Canada Community-Acquired Pneumonia: A One-year Follow-up Study/ R. Méndez Ocaña, Valencia, Spain P49 Cardiopulmonary Changes in Patients Recovering From Acute COVID-19 Disease: A Prospective Observational Study/ L.P.V. Kattamuri, New Delhi, India P50 Thymic Hyperplasia After Severe SARS-CoV-2 Pneumonia/ M.J. Cavaco, Torres Vedras, Portugal P48 Long-term Mortality in COVID-19 and

P25 Mortality and Hospitalization Outcomes Among Vaccinated Compared to Unvaccinated COVID-19 Patients/ M. Ghaly, Dothan, AL P26 The Ontario Multi-Regional Hospital Coronavirus Registry (COREG)-Lung Recovery Trajectory Sub-study/ J. Kapralik, Hamilton, Canada P27 Fatal COVID 19 Infection in an Adult Patient With Hospitalized for COVID-19/ S.M. Frent, Timisoara, Romania P29 COVID: The Cranberry of Viral Illnesses/ T.A. D’Amico, Norwalk, CT P30 Sars_Cov2 Infection and Its Impact on Cystic Fibrosis Patients - An Indian Study/ V. Kizhikkilot, Chennai Tamil Nadu, India P31 Defining Predicting Factors for In Hospital Mortality of COVID-19 Patients/ D. Handayani, Jakarta Timur, Indonesia P32 Comparison of the Clinical and Virological Characteristics of SARS-COV-2 Omicron BA.1/BA.2 and Omicron BA.5 Variants: A Prospective Cohort Study/ S.-W. Kang, Seoul, Korea, Republic of P33 Airway Epithelial Repair and SARS-CoV-2 Spike S1 Protein Treatment/ T. Guo, Vancouver, Canada P34 Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19/ L. Gori, Florence, Italy P35 Autoantibody Profiles Differ in Immunocompromised Hospitalized COVID-19 Patients, But Are Not Associated With Mortality/ H.D. Morin, Stanford, CA P36 Diverse Gene Mutations by Molnupiravir After B-Cell Depletion Therapy: Report of 2 COVID-19 Cases/ T. Masuda, Shizuoka, Japan P37 Prolonged COVID-19 Infection in B-cell Impairment and Treatment With Intravenous Immunoglobulin (IVIG)/ S. Mehta, Saint Louis, MO P38 COVID-19 Vaccination Is Not Associated With Abnormal Patient Reported Outcome Measures in Patients With Long-COVID: A Prospective Cohort Study/ S.-E.-D. El-Akkad, Vancouver, Canada P39 SARS-CoV-2: Playing by the Ear/ N.R. Perkit, Worcester, MA P40 Clinical Development of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients With COVID-19 in the Home and Hospital Settings/ P.D. Monk, Southampton, United Kingdom P41 When Humoral Immunity Fails Due to Rituximab in COVID-19 Pneumonia/ P. Ho, Wynnewood, PA Previous Miliary Tuberculosis: A Case Report/ P. Pintac, Manila City, Philippines P28 Improved Survival in Highly Religious Patients

CLINICAL THEMATIC POSTER SESSION

B62

FUNGI EVERYWHERE!

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area A, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P52 Precision Cut Lung Slices (PCLS) as an Ex Vivo Model to Study Pneumocystis Murina Survival/Growth/ F.T. Munyonho, New Orleans, LA P53 Characteristics of Pleural Coccidioidomycosis, a Single Center Experience/ A.A. Abdalla, Phoenix, AZ P54 Lung Cavity - A Mystery/ T.H. Rahmlow, Harlan, KY P55 Pulmonary Mucormycosis Requiring Cryoextraction: A Case Report and Literature Review/ A. Jahangir, Oklahoma City, OK

ATS 2023 • Washington, DC